Publications by authors named "Jaume Olives"

Claim this Profile
D
Design and validation of the 1-week memory battery for assessing episodic memory and accelerated long-term forgetting in cognitively unimpaired subjects.
Lorena Rami, María León, Natalia Valech, Nina Coll-Padrós, Beatriz Bosch, Jaume Olives

Neuropsychology· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early-onset Alzheimer's disease shows a distinct neuropsychological profile and more aggressive trajectories of cognitive decline than late-onset.
Adrià Tort-Merino, Neus Falgàs, Isabel E Allen, Mircea Balasa, Jaume Olives

Ann Clin Transl Neurol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Baseline MRI atrophy predicts 2-year cognitive outcomes in early-onset Alzheimer's disease.
José Contador, Agnès Pérez-Millan, Nuria Guillen, Adrià Tort-Merino, Mircea Balasa, Jaume Olives

J Neurol· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Longitudinal brain atrophy and CSF biomarkers in early-onset Alzheimer's disease.
José Contador, Agnès Pérez-Millán, Adrià Tort-Merino, Mircea Balasa, Neus Falgàs, Jaume Olives

Neuroimage Clin· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Accelerated long-term forgetting in individuals with subjective cognitive decline and amyloid-β positivity.
Adrià Tort-Merino, Natalia Valech, Matti Laine, Jaume Olives, María León

Int J Geriatr Psychiatry· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnostic Accuracy of MRI Visual Rating Scales in the Diagnosis of Early Onset Cognitive Impairment.
Neus Falgàs, Mircea Balasa, Núria Bargalló, Sergi Borrego-Écija, Oscar Ramos-Campoy, Jaume Olives

J Alzheimers Dis· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modelling the cascade of biomarker changes in -related frontotemporal dementia.
Jessica L Panman, Vikram Venkatraghavan, Emma L van der Ende, Rebecca M E Steketee, Lize C Jiskoot, Jaume Olives

J Neurol Neurosurg Psychiatry· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Accelerated long-term forgetting over three months in asymptomatic APOE ɛ4 carriers.
Adrià Tort-Merino, Matti Laine, Natalia Valech, Jaume Olives, María León

Ann Clin Transl Neurol· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Associations Between the Subjective Cognitive Decline-Questionnaire's Scores, Gray Matter Volume, and Amyloid-β Levels.
Natalia Valech, Gonzalo Sánchez-Benavides, Adrià Tort-Merino, Nina Coll-Padrós, Jaume Olives

J Alzheimers Dis· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tau Protein is Associated with Longitudinal Memory Decline in Cognitively Healthy Subjects with Normal Alzheimer's Disease Cerebrospinal Fluid Biomarker Levels.
Adrià Tort-Merino, Jaume Olives, María León, Claudia Peñaloza, Natalia Valech

J Alzheimers Dis· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Screening of dementia genes by whole-exome sequencing in Spanish patients with early-onset dementia: likely pathogenic, uncertain significance and risk variants.
Oscar Ramos-Campoy, Anna Antonell, Neus Falgàs, Mircea Balasa, Sergi Borrego-Écija, Jaume Olives

Neurobiol Aging· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hippocampal atrophy has limited usefulness as a diagnostic biomarker on the early onset Alzheimer's disease patients: A comparison between visual and quantitative assessment.
Neus Falgàs, Raquel Sánchez-Valle, Núria Bargalló, Mircea Balasa, Guadalupe Fernández-Villullas, Jaume Olives

Neuroimage Clin· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Contribution of CSF biomarkers to early-onset Alzheimer's disease and frontotemporal dementia neuroimaging signatures.
Neus Falgàs, Mariona Ruiz-Peris, Agnès Pérez-Millan, Roser Sala-Llonch, Anna Antonell, Jaume Olives

Hum Brain Mapp· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early detection of subtle motor dysfunction in cognitively normal subjects with amyloid-β positivity.
Maria A Mollica, Adrià Tort-Merino, Jordi Navarra, Irune Fernández-Prieto, Natalia Valech, Jaume Olives

Cortex· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel P397S MAPT variant associated with late onset and slow progressive frontotemporal dementia.
Sergi Borrego-Écija, Anna Antonell, Joan Anton Puig-Butillé, Inmaculada Pericot, Carme Prat-Bravo, Jaume Olives

Ann Clin Transl Neurol· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Executive and Language Subjective Cognitive Decline Complaints Discriminate Preclinical Alzheimer's Disease from Normal Aging.
Natalia Valech, Adrià Tort-Merino, Nina Coll-Padrós, Jaume Olives, María León

J Alzheimers Dis· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The hippocampal longitudinal axis-relevance for underlying tau and TDP-43 pathology.
Albert Lladó, Adrià Tort-Merino, Raquel Sánchez-Valle, Neus Falgàs, Mircea Balasa, Jaume Olives

Neurobiol Aging· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early Detection of Learning Difficulties when Confronted with Novel Information in Preclinical Alzheimer's Disease Stage 1.
Adrià Tort-Merino, Natalia Valech, Claudia Peñaloza, Petra Grönholm-Nyman, María León, Jaume Olives

J Alzheimers Dis· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Subtle visuomotor difficulties in preclinical Alzheimer's disease.
Maria A Mollica, Jordi Navarra, Irune Fernández-Prieto, Jaume Olives, Adrià Tort

J Neuropsychol· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cerebrospinal Fluid Biomarkers Predict Clinical Evolution in Patients with Subjective Cognitive Decline and Mild Cognitive Impairment.
Alba Sierra-Rio, Mircea Balasa, Jaume Olives, Anna Antonell, Alex Iranzo

Neurodegener Dis· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Informants' Perception of Subjective Cognitive Decline Helps to Discriminate Preclinical Alzheimer's Disease from Normal Aging.
Natalia Valech, María A Mollica, Jaume Olives, Adriá Tort, Juan Fortea

J Alzheimers Dis· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cerebrospinal fluid level of YKL-40 protein in preclinical and prodromal Alzheimer's disease.
Anna Antonell, Alicia Mansilla, Lorena Rami, Albert Lladó, Alex Iranzo, Jaume Olives

J Alzheimers Dis· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Subjective Cognitive Decline Questionnaire (SCD-Q): a validation study.
Lorena Rami, Maria A Mollica, Carmen García-Sanchez, Judith Saldaña, Belen Sanchez, Jaume Olives

J Alzheimers Dis· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Usefulness of biomarkers in the diagnosis and prognosis of early-onset cognitive impairment.
Mircea Balasa, Raquel Sánchez-Valle, Anna Antonell, Beatriz Bosch, Jaume Olives

J Alzheimers Dis· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
White matter changes in preclinical Alzheimer's disease: a magnetic resonance imaging-diffusion tensor imaging study on cognitively normal older people with positive amyloid β protein 42 levels.
José Luis Molinuevo, Pablo Ripolles, Marta Simó, Albert Lladó, Jaume Olives

Neurobiol Aging· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis